Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Bringing clarity to cancer. Working to ensure that everyone touched by cancer has a clear path to the right care.
Orionis Biosciences operates in the healthcare industry focusing on biotechnology business & innovation.
Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.
Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
Relation Therapeutics is a biotechnology company that focuses on humanizing drug discovery and development.
Octave is a precision care company that provides diagnostic tools and care solutions for neurodegenerative diseases.
Deciphex builds a network of AI empowered pathologists ensuring accessible pathology services that improves patient outcomes.
IKAS Industrial Automation is provides intelligent manufacturing solutions for IC manufacturing and packaging testing, LED, photovoltaic.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Xealth is a digital health platform that enables healthcare organizations to prescribe and monitor health tools, programs, and services.
Jiamai is a new energy pneumatic component manufacturer.
Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
Borealis Biosciences is a company in the field of next-generation RNA medicines.
LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
Patientory is a patient data platform that empowers individuals to control their health data and earn personalized rewards.
FundaMental Pharma is a neuroscience company with a portfolio at the preclinical stage.
Lightship is making clinical trials more accessible for patients and providers to accelerate development of better therapies for all.
Holmusk is a provider of healthcare data and technology solutions to support the treatment of mental health and chronic diseases.
Novartis has invested in 101 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novartis's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Artificial Intelligence (AI). The firm invests across 27 different industry categories.
Among tracked funding rounds, Aktis Oncology received $175.0M in a Series B round. Novartis's total known invested capital is $2.8B.
Novartis's average investment size is $54.3M across its portfolio of 101 companies.
Recent Novartis portfolio additions include COTA Healthcare, Orionis Biosciences, Anokion, Rani Therapeutics, C4 Therapeutics. These companies were founded in 2020 or later.